Yasin Keshvargar
Lawyers
Filters
Samarco Mineração enters into restructuring support agreement
We are advising an ad hoc group in connection with the restructuring
XPO $1.28 billion senior notes offerings
The senior notes are due 2028 and 2031
Emergent BioSolutions $150 million at-the-market offering
The shares are listed on the NYSE
GSK exclusive licensing agreement with Scynexis
We advised GSK on the transaction
InflaRx follow-on offering
The shares are listed on the Nasdaq Global Market
Ormat Technologies $297 million follow-on offering
The stock is listed on the NYSE and Tel Aviv Stock Exchange
Alteryx $450 million senior notes offering
The 8.75% notes are due 2028
Stanley Black & Decker $750 million notes offering
The investment-grade notes are due 2026 and 2028
Eli Lilly $4 billion notes offering
The investment-grade notes are due 2026, 2033, 2053 and 2063
ADC Therapeutics secondary offering
We advised ADC Therapeutics on the registered secondary offering of its shares